Latest News
|
More Articles...
- People with HIV Are at Increased Risk for Heart Failure
- Restore Medical Announces First in Human Trial for Treatment of Heart Failure in Patients
- Study Finds 89% of Patients Treated for Persistent Atrial Fibrillation Using Abbott’s Ablation Device Remain Symptom-Free for at Least 15 Months
- Tackling Health Disparities and Inequities for Women with Heart Failure: New Program Encourages Black and Latina Women to Demand More from Their Care
- US FDA Approves Jardiance® (Empagliflozin) to Treat Adults with Heart Failure Regardless of Left Ventricular Ejection Fraction
- Xcardia Announces First-In-Human Use of its New Xtractor Device for Cardiac Pacemaker and Defibrillator Lead Extraction Procedures
- Abbott Announces World’s First Implant of Dual-Chamber Leadless Pacemaker in Pivotal Trial
- Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms
- Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms
- Abbott’s CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-stage Heart Failure
|
|
